tradingkey.logo
tradingkey.logo
Pesquisar

Biofrontera Inc

BFRI
Adicionar à lista de desejos
1.010USD
0.0000.00%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
11.76MValor de mercado
PerdaP/L TTM

Mais detalhes de Biofrontera Inc Empresa

Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.

Informações de Biofrontera Inc

Código da empresaBFRI
Nome da EmpresaBiofrontera Inc
Data de listagemOct 14, 2021
CEOLuebbert (Hermann)
Número de funcionários92
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 14
Endereço120 Presidential Way,
CidadeWOBURN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01801
Telefone17812451325
Sitehttps://www.biofrontera-us.com/
Código da empresaBFRI
Data de listagemOct 14, 2021
CEOLuebbert (Hermann)

Executivos da empresa Biofrontera Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
290.21K
+47.38%
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
175.00K
+50.00%
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--
Mr. George Jones
Mr. George Jones
Chief Commercial Officer
Chief Commercial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
290.21K
+47.38%
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
175.00K
+50.00%
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Biofrontera Inc?

Os cinco principais acionistas de Biofrontera Inc são: Prof. Dr. Hermann Luebbert, Ph.D.

Quantas instituições possuem ações da Biofrontera Inc (BFRI)?

Em 2026Q1, 37 instituições possuíam ações da Biofrontera Inc, com valor de mercado aproximado de 2.75M, representando 22.90% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -276665.00.